Adequan Canine is administered by intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints. Adequan Canine contains polysulfated glycosaminoglycan (PSGAG). Polysulfated glycosaminoglycan is characterized as a "disease modifying osteoarthritis drug." Adequan Canine contains 100 mg/ml of polysulfated glycosaminoglycan. The recommended dose of Adequan Canine is 2 mg/lb body weight (.02 mL/lb, or 1 mL per 50 lb), by intramuscular injection only, twice weekly for up to 4 weeks.
Contents: Two (100mg / mL), 5 mL Vials
